ANGIONI, MARIA MADDALENA
 Distribuzione geografica
Continente #
EU - Europa 62.339
NA - Nord America 2.755
AS - Asia 1.373
SA - Sud America 171
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 41
OC - Oceania 14
Totale 66.829
Nazione #
IT - Italia 61.453
US - Stati Uniti d'America 2.679
SG - Singapore 484
CN - Cina 409
DE - Germania 299
SE - Svezia 156
BR - Brasile 135
VN - Vietnam 135
FI - Finlandia 94
UA - Ucraina 76
GB - Regno Unito 75
HK - Hong Kong 70
CA - Canada 52
BD - Bangladesh 50
FR - Francia 50
IN - India 40
JP - Giappone 35
RU - Federazione Russa 29
ES - Italia 23
KR - Corea 22
TR - Turchia 20
NL - Olanda 18
IQ - Iraq 16
ZA - Sudafrica 15
AU - Australia 14
PL - Polonia 14
LT - Lituania 10
PK - Pakistan 10
BE - Belgio 9
IR - Iran 9
AR - Argentina 8
EG - Egitto 8
ID - Indonesia 8
MY - Malesia 8
UZ - Uzbekistan 8
CL - Cile 7
MA - Marocco 7
PH - Filippine 7
AT - Austria 6
CO - Colombia 6
MX - Messico 6
TW - Taiwan 6
AZ - Azerbaigian 5
EC - Ecuador 5
GR - Grecia 5
SA - Arabia Saudita 5
DZ - Algeria 4
IE - Irlanda 4
JM - Giamaica 4
JO - Giordania 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
KZ - Kazakistan 1
ML - Mali 1
MR - Mauritania 1
MV - Maldive 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 66.693
Città #
Cagliari 59.993
Uta 1.239
Singapore 287
Dallas 283
Ashburn 281
San Jose 176
Chandler 146
Boardman 121
Houston 107
Fairfield 102
Los Angeles 91
Nyköping 86
Beijing 84
Woodbridge 76
Helsinki 73
Council Bluffs 68
Ann Arbor 67
Hong Kong 60
New York 60
Wilmington 56
Dearborn 53
Cambridge 51
Seattle 50
Santa Clara 48
The Dalles 44
Shanghai 42
Jacksonville 41
Ho Chi Minh City 38
Chicago 33
Lauterbourg 33
Munich 33
Dong Ket 28
Boston 25
Rome 24
Hefei 23
Buffalo 22
Milan 22
Hanoi 20
Tokyo 19
Denver 18
Seoul 17
Atlanta 16
Orem 16
London 15
Nanjing 15
Brooklyn 14
Frankfurt am Main 13
Columbus 12
Nuremberg 12
São Paulo 12
Madrid 11
Warsaw 11
Amsterdam 10
Mumbai 10
Redondo Beach 10
San Diego 10
Toronto 10
Vancouver 10
Brussels 9
Changsha 9
Manchester 9
Montreal 9
Phoenix 9
Rio de Janeiro 9
Shenzhen 9
Baghdad 8
Brisbane 8
Chennai 8
Düsseldorf 8
Elk Grove Village 8
Guangzhou 8
Stockholm 8
Da Nang 7
Redwood City 7
Salt Lake City 7
Tashkent 7
Zola Predosa 7
Johannesburg 6
Leawood 6
San Francisco 6
Selargius 6
Turku 6
Zhengzhou 6
Charlotte 5
City of London 5
Dhaka 5
Jinan 5
Kocaeli 5
Miami 5
Nanchang 5
Ningbo 5
Norwalk 5
Paris 5
San Mateo 5
Sestu 5
Springfield 5
Tampa 5
Tianjin 5
Ankara 4
Athens 4
Totale 64.620
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.756
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.069
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.671
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.208
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.189
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.075
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.074
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.915
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.834
NRF2 mutations are frequent in early rat preneoplastic hepatic lesions and in human hepatocellular carcinomas positive for the stem/progenitor cell marker KRT-19 2.799
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.745
Spa therapy induces clinical improvement and protein changes in patients with chronic back pain 2.270
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.266
Neonatal exposure to estradiol in rats influences neuroactive steroid concentrations, GABA(A) receptor expression, and behavioral sensitivity to anxiolytic drugs 2.056
La somministrazione neonatale di estrogeno modifica i livelli di steroidi neuroattivi, la plasticità dei recettori GABAA e la sensibilitò ai farmaci ansiolitici nelle femmine adulte 1.877
Changes in neuroactive steroids levels, GABAA receptor plasticity and sensitivity to anxiolytic drugs induced by neonatal exposure to estrogen 1.828
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.664
Changes in neuroactive steroid levels, GABAA receptor plasticity and sensitivity to anxiolytic drugs induced by neonatal exposure to estrogen 1.621
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.207
Targeted Therapies in Axial Psoriatic Arthritis 1.188
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.078
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.071
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.061
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 1.010
Response to treatment with chemical and biological inhibitors of c-met mutated form 908
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 785
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 730
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 568
GRAPPA 2020 Research Award Recipients 505
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review 337
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 188
The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis 102
The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways 75
Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials 65
The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study 34
Totale 66.829
Categoria #
all - tutte 82.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.026 0 198 113 183 281 223 180 203 333 408 465 439
2022/20235.102 506 797 702 459 451 509 244 282 289 325 346 192
2023/20246.650 241 163 216 444 797 764 754 1.457 276 303 662 573
2024/202520.071 8.075 4.996 3.771 1.023 503 578 638 50 88 90 146 113
2025/20263.327 189 192 360 248 259 190 647 269 243 285 344 101
2026/2027400 257 143 0 0 0 0 0 0 0 0 0 0
Totale 66.829